Structure Therapeutics Inc. GPCR
We take great care to ensure that the data presented and summarized in this overview for Structure Therapeutics Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in GPCR
Top Purchases
Top Sells
About GPCR
Insider Transactions at GPCR
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2025
|
Raymond C Stevens CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
16,050
-1.33%
|
$96,300
$6.84 P/Share
|
|
Jul 01
2025
|
Raymond C Stevens CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
89,697
+6.9%
|
-
|
|
Jul 01
2025
|
Jun Yoon CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,089
-0.53%
|
$42,534
$6.84 P/Share
|
|
Jul 01
2025
|
Jun Yoon CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
39,606
+2.9%
|
-
|
|
Jul 01
2025
|
Xichen Lin CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
57,078
+20.81%
|
-
|
|
Jul 01
2025
|
Yingli Ma CHIEF TECHNOLOGY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
24,459
+16.57%
|
-
|
|
Jul 01
2025
|
Crespo Blas Coll CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,434
-0.63%
|
$8,604
$6.84 P/Share
|
|
Jul 01
2025
|
Crespo Blas Coll CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
7,992
+3.41%
|
-
|
|
Mar 15
2025
|
Raymond C Stevens CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
340,332
+23.09%
|
-
|
|
Mar 15
2025
|
Jun Yoon CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
170,166
+11.63%
|
-
|
|
Mar 15
2025
|
Xichen Lin CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
80,829
+32.68%
|
-
|
|
Mar 15
2025
|
Yingli Ma CHIEF TECHNOLOGY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
63,810
+38.83%
|
-
|
|
Mar 15
2025
|
Ashley Hall Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,048
+30.14%
|
-
|
|
Mar 15
2025
|
Crespo Blas Coll CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
116,988
+34.76%
|
-
|
|
Mar 01
2025
|
Raymond C Stevens CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
12,495
-1.1%
|
$87,465
$7.92 P/Share
|
|
Mar 01
2025
|
Jun Yoon CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,940
-0.46%
|
$41,580
$7.92 P/Share
|
|
Mar 01
2025
|
Xichen Lin CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
6,441
-3.87%
|
$45,087
$7.92 P/Share
|
|
Mar 01
2025
|
Yingli Ma CHIEF TECHNOLOGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,824
-1.81%
|
$12,768
$7.92 P/Share
|
|
Mar 01
2025
|
Crespo Blas Coll CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,233
-0.56%
|
$8,631
$7.92 P/Share
|
|
Sep 18
2024
|
Ashley Hall Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
67,290
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
1.2M
Shares
From
6
Insiders
| Grant, award, or other acquisition | 1.2M shares |
|---|
Sell / Disposition
52.5K
Shares
From
5
Insiders
| Payment of exercise price or tax liability | 52.5K shares |
|---|